DK168322B1 - Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet - Google Patents

Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet Download PDF

Info

Publication number
DK168322B1
DK168322B1 DK359387A DK359387A DK168322B1 DK 168322 B1 DK168322 B1 DK 168322B1 DK 359387 A DK359387 A DK 359387A DK 359387 A DK359387 A DK 359387A DK 168322 B1 DK168322 B1 DK 168322B1
Authority
DK
Denmark
Prior art keywords
solutions
oxazaphosphorins
ethanol
cyclophosphamide
preparation
Prior art date
Application number
DK359387A
Other languages
Danish (da)
English (en)
Other versions
DK359387D0 (da
DK359387A (da
Inventor
Otto Isaac
Dieter Sauerbier
Klaus Molge
Werner Weigert
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of DK359387D0 publication Critical patent/DK359387D0/da
Publication of DK359387A publication Critical patent/DK359387A/da
Application granted granted Critical
Publication of DK168322B1 publication Critical patent/DK168322B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Paper (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
DK359387A 1986-07-11 1987-07-10 Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet DK168322B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3623369 1986-07-11
DE3623369 1986-07-11

Publications (3)

Publication Number Publication Date
DK359387D0 DK359387D0 (da) 1987-07-10
DK359387A DK359387A (da) 1988-01-12
DK168322B1 true DK168322B1 (da) 1994-03-14

Family

ID=6304930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK359387A DK168322B1 (da) 1986-07-11 1987-07-10 Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet

Country Status (16)

Country Link
US (1) US4952575A (fi)
EP (1) EP0254902B1 (fi)
JP (1) JPS6323888A (fi)
KR (1) KR880001282A (fi)
AT (1) ATE66609T1 (fi)
AU (1) AU598282B2 (fi)
CA (1) CA1289886C (fi)
DE (2) DE3772482D1 (fi)
DK (1) DK168322B1 (fi)
ES (1) ES2038623T3 (fi)
FI (1) FI86690C (fi)
GR (1) GR3002618T3 (fi)
IE (1) IE59897B1 (fi)
IL (1) IL83141A (fi)
PT (1) PT85293B (fi)
ZA (1) ZA875059B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1999018973A2 (de) * 1997-10-13 1999-04-22 Stada Arzneimittel Ag Flüssige darreichungsformen oxazaphosphorinhaltiger pharmazeutischer produkte
US7205404B1 (en) * 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
AUPQ849900A0 (en) * 2000-06-30 2000-07-27 Dbl Australia Pty Ltd. Injectable composition
US6613927B1 (en) 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
US20050272698A1 (en) * 2002-09-05 2005-12-08 Daftary Gautam V Liquid stable composition of oxazaphosphorine with mesna
US7199111B2 (en) * 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
EP3623364A1 (en) 2014-02-13 2020-03-18 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
BR112016026140A2 (pt) * 2014-05-09 2018-08-07 AuroMedics Pharma LLC formulações de concentrado líquido de ciclofosfamida.
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途
WO2016005962A2 (en) 2014-07-11 2016-01-14 Dr. Reddy’S Laboratories Limited Stable liquid formulations of cyclophosphamide and processes
US10849916B2 (en) 2014-07-11 2020-12-01 Dr. Reddys Laboratories Limited Stable liquid formulations of cyclophosphamide and its impurities
US10993952B2 (en) * 2015-02-16 2021-05-04 Leiutis Pharmaceuticals Pvt. Ltd. Stable ready to use cyclophosphamide liquid formulations
JP2021509907A (ja) 2018-01-09 2021-04-08 リガンド・ファーマシューティカルズ・インコーポレイテッド アセタール化合物およびその治療的使用
WO2022038072A1 (en) * 2020-08-17 2022-02-24 Sandoz Ag Parenteral pharmaceutical composition comprising cyclophosphamide and a mixture of liquids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3530147A1 (de) * 1985-08-23 1987-02-26 Bayer Ag Verwendung von diazaphosphorinen zur bekaempfung von endoparasiten

Also Published As

Publication number Publication date
IL83141A (en) 1992-11-15
IE871867L (en) 1988-01-11
DE3722043A1 (de) 1988-01-14
US4952575A (en) 1990-08-28
AU7554987A (en) 1988-01-14
CA1289886C (en) 1991-10-01
EP0254902B1 (de) 1991-08-28
DE3772482D1 (de) 1991-10-02
EP0254902A2 (de) 1988-02-03
GR3002618T3 (en) 1993-01-25
ATE66609T1 (de) 1991-09-15
EP0254902A3 (en) 1988-08-03
AU598282B2 (en) 1990-06-21
FI86690C (fi) 1992-10-12
IE59897B1 (en) 1994-04-20
ZA875059B (en) 1988-02-24
DK359387D0 (da) 1987-07-10
IL83141A0 (en) 1987-12-31
FI873064A0 (fi) 1987-07-10
PT85293B (pt) 1990-03-30
KR880001282A (ko) 1988-04-22
ES2038623T3 (es) 1993-08-01
JPS6323888A (ja) 1988-02-01
JPH0543711B2 (fi) 1993-07-02
FI873064A (fi) 1988-01-12
PT85293A (de) 1987-08-01
DK359387A (da) 1988-01-12
FI86690B (fi) 1992-06-30

Similar Documents

Publication Publication Date Title
DK168322B1 (da) Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet
JPS62242618A (ja) 水銀含有防腐剤を安定化した眼炎治療薬
BG107788A (bg) Фармацевтични състави на nmda рецепторен агонист
PT90124B (pt) Processo para a preparacao de composicoes farmaceuticas de piroxicamo em solucoes aquosas
JP2012162577A (ja) がん治療のための細胞増殖抑制剤及び電子受容体を含有する医薬製剤
KR20170008252A (ko) 사이클로포스파미드 액상 농축 제제
CZ281142B6 (cs) Roztoky léčiva se zvýšenou stabilitou a bez účinků poškozujících tkáň a způsob jejich přípravy
CN101123957B (zh) 双氯芬酸及其药学上可接受盐的注射剂
JP6018048B2 (ja) 注射用イブプロフェン医薬組成物
TW455491B (en) Pharmaceutical composition for oral administration
RU2157687C2 (ru) Фармацевтические составы для парентерального введения, содержащие n-{4-[2-(1,2,3,4-тетрагидро-6,7-диметокси-2-изохинолинил)-этил]-фенил]-9,1 0-дигидро-5-метокси-9-оксо-4-акридинкарбоксамид
WO2007008350A1 (en) Pharmaceutical formulations of endo-n-(9- methyl-9-azabicyclo[3 .3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride
PT90356B (pt) Processo para a preparacao de composicoes farmaceuticas contendo solucoes aquosas de pentamidina
AU2007271431A1 (en) Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid
RU2272623C2 (ru) РАСТВОР ТЕТРАГИДРАТА МОНОНАТРИЕВОЙ СОЛИ N-[O-(п-ПИВАЛОИЛОКСИБЕНЗОЛСУЛЬФОНИЛАМИНО)БЕНЗОИЛ]ГЛИЦИНА И ГОТОВАЯ ЛЕКАРСТВЕННАЯ ФОРМА НА ЕГО ОСНОВЕ
TW200934533A (en) Antimicrobial N-halogenated amino acid salts
JPH03130226A (ja) １つより多いエチレンイミン基を有する抗新生物性化合物用の安定な製薬学的配合及び方法
HU220867B1 (en) Pharmaceutical compositions as a solution, containing bis-triazole derivatives and process for producing them
JP4475405B2 (ja) 医薬組成物
JP3956654B2 (ja) Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物含有溶液および製剤
RU2680804C1 (ru) Стабильное средство лечения болезней суставов
DK155144B (da) Fremgangsmaade til fremstilling af stabile oploesninger af en blanding af hydrogenerede ergotalkaloider og heparin
US20240269299A1 (en) Polyethylene glycol-drug conjugate and use thereof
FR2714291A1 (fr) Application des dérivés de la pyridone à titre de médicaments anesthésiques.
AT390881B (de) Verfahren zur herstellung von pharmazeutischen loesungen von oxazaphosphorinen mit verbesserter stabilitaet

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired